Market Cap 479.91M
Revenue (ttm) 84.04M
Net Income (ttm) -4.31M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin -5.13%
Debt to Equity Ratio 0.05
Volume 901,700
Avg Vol 697,366
Day's Range N/A - N/A
Shares Out 1.08B
Stochastic %K 36%
Beta 0.32
Analysts Strong Buy
Price Target N/A

Company Profile

Elite Pharmaceuticals, Inc., a specialty pharmaceutical company, engages in the development, manufacture, and sale of oral, controlled-release products, and generic pharmaceuticals. The company operates through Abbreviated New Drug Applications for Generic Pharmaceuticals and New Drug Applications for Branded Pharmaceuticals segments. It owns, licenses, manufactures, and sales of generic, oral dose pharmaceuticals products, such as Phentermine HCl 37.5mg tablets, and 15mg and 30mg capsules for t...

Industry: Drug Manufacturers - Specialty & Generic
Sector: Healthcare
Phone: 201 750 2646
Fax: 201 750 2755
Address:
165 Ludlow Avenue, Northvale, United States
clan
clan Jan. 29 at 12:43 PM
$ELTP In a couple weeks, when Elite reports qrt.-ended 12/31/25 results, it is going to BLOW AWAY Revenues for the same qrt., previous year!!! Heads will turn! $TEVA $JNJ
1 · Reply
Abracadabrah
Abracadabrah Jan. 29 at 2:19 AM
$ELTP I’ll take anything over a $1 at this point. If this goes $3 or more…everybody in my circle will hate me for bringing this stock up every single day until I’m dead for how much they made fun of me for sticking to my guns and throwing a giant bag at it.
0 · Reply
PalladiumMidas19
PalladiumMidas19 Jan. 28 at 11:09 PM
$ELTP 99¢
2 · Reply
mscp
mscp Jan. 28 at 10:15 PM
$ELTP any guesses on buyout price if it happens ? I’m Thinking $3-$4 range.
2 · Reply
flyinlow
flyinlow Jan. 28 at 2:50 PM
$ELTP I just don’t get it w/ this stock. Are we just supposed to just go on & be satisfied that we’re losing $$? They don’t tell us anything at all. WHY NOT?
1 · Reply
BarkingPuppy
BarkingPuppy Jan. 28 at 1:52 PM
$ELTP Here We Go!!!!!!!!!!
0 · Reply
Abracadabrah
Abracadabrah Jan. 27 at 9:03 PM
$ELTP It’s just money at the end of the day. who really cares.
1 · Reply
PalladiumMidas19
PalladiumMidas19 Jan. 27 at 7:49 PM
$ELTP hitting .30s this week?
0 · Reply
LieutenantJoe
LieutenantJoe Jan. 27 at 6:42 PM
0 · Reply
Sdk2424
Sdk2424 Jan. 27 at 6:36 PM
$ELTP we are now 2.5 cents away from when I purchased over 24 years ago. The company did absolutely nothing then and was hoping for a big win with a narcotic deterrent medication. Now the company has exploded with approvals, sales and distribution rights and the share price is still pathetic!! The only difference now is that the insiders were ankle to spend pennies on warrant conversion and make millions !!! If Nas was my uncle I would have used his head as a piñata just to see the confetti fly out!! He’s a waste and f good oxygen!!! POS CEO!!!
1 · Reply
Latest News on ELTP
No data available.
clan
clan Jan. 29 at 12:43 PM
$ELTP In a couple weeks, when Elite reports qrt.-ended 12/31/25 results, it is going to BLOW AWAY Revenues for the same qrt., previous year!!! Heads will turn! $TEVA $JNJ
1 · Reply
Abracadabrah
Abracadabrah Jan. 29 at 2:19 AM
$ELTP I’ll take anything over a $1 at this point. If this goes $3 or more…everybody in my circle will hate me for bringing this stock up every single day until I’m dead for how much they made fun of me for sticking to my guns and throwing a giant bag at it.
0 · Reply
PalladiumMidas19
PalladiumMidas19 Jan. 28 at 11:09 PM
$ELTP 99¢
2 · Reply
mscp
mscp Jan. 28 at 10:15 PM
$ELTP any guesses on buyout price if it happens ? I’m Thinking $3-$4 range.
2 · Reply
flyinlow
flyinlow Jan. 28 at 2:50 PM
$ELTP I just don’t get it w/ this stock. Are we just supposed to just go on & be satisfied that we’re losing $$? They don’t tell us anything at all. WHY NOT?
1 · Reply
BarkingPuppy
BarkingPuppy Jan. 28 at 1:52 PM
$ELTP Here We Go!!!!!!!!!!
0 · Reply
Abracadabrah
Abracadabrah Jan. 27 at 9:03 PM
$ELTP It’s just money at the end of the day. who really cares.
1 · Reply
PalladiumMidas19
PalladiumMidas19 Jan. 27 at 7:49 PM
$ELTP hitting .30s this week?
0 · Reply
LieutenantJoe
LieutenantJoe Jan. 27 at 6:42 PM
0 · Reply
Sdk2424
Sdk2424 Jan. 27 at 6:36 PM
$ELTP we are now 2.5 cents away from when I purchased over 24 years ago. The company did absolutely nothing then and was hoping for a big win with a narcotic deterrent medication. Now the company has exploded with approvals, sales and distribution rights and the share price is still pathetic!! The only difference now is that the insiders were ankle to spend pennies on warrant conversion and make millions !!! If Nas was my uncle I would have used his head as a piñata just to see the confetti fly out!! He’s a waste and f good oxygen!!! POS CEO!!!
1 · Reply
flyinlow
flyinlow Jan. 27 at 5:21 PM
0 · Reply
Scipio88
Scipio88 Jan. 26 at 5:51 PM
@RunningRobert1 $ELTP Is getting dangerously low in stock price for me. Any idea what's going on with ELTP? I'm getting nervous with this downtrend.
4 · Reply
dillydally1
dillydally1 Jan. 26 at 4:11 PM
$ELTP ok back in this thing with 11k shares… let’s do that buyout lol
0 · Reply
TraderDaKing
TraderDaKing Jan. 26 at 2:34 PM
$ELTP lets go!!!!!!!
0 · Reply
Investor55342
Investor55342 Jan. 26 at 9:03 AM
0 · Reply
DMFDMinister
DMFDMinister Jan. 26 at 5:37 AM
$ELTP approaching long term support from august 2023. Could see .38. Loaded for some panic sellers. Got about 100k and definitely will pick up more should this reach long term support. Looks like by March if nothing changes
0 · Reply
Bok987
Bok987 Jan. 24 at 3:47 PM
$ELTP I googled Elite pharmacuetical rumor:I Overview As of early 2026, Elite Pharmaceuticals (ELTP) is surrounded by speculation regarding potential corporate restructuring or a buyout, following a board announcement in late 2025 regarding the evaluation of a merger with Sunbridge Agro Private Limited, Landsmill Agro Private Limited, and Golden Cryo Private Limited. The company reported strong fiscal 2026 Q1 and Q2 results, with significant revenue growth driven by generic product sales and a pipeline of abuse-deterrent opioids. Key points regarding recent rumors and developments: Merger/Buyout Speculation: The board announced it was evaluating a strategic merger involving multiple private entities. Investors have speculated on potential buyout scenarios, although no formal, confirmed sale has been announced as of January 2026. Strong Finance.
0 · Reply
Adjdjfldb
Adjdjfldb Jan. 23 at 7:47 PM
$ELTP picked up 33000 more shares today. Up to 343000.
0 · Reply
Zfresh
Zfresh Jan. 23 at 2:41 PM
$ELTP I agree. Been too quiet. Listen to the last couple of earnings calls or at least the last one. Strong language of buyout early 2026. Earnings in a few weeks. Probably a great time to enter or buy more. I sold a good bit in early December at my highest cost shares to take a tax loss and am buying back next week. I will have a good bit of tax free profits when this goes 2-4x. You really can’t go wrong at this price. Even with no buy out, this company continues to have strong earnings after earnings.
0 · Reply
FightingIrish33
FightingIrish33 Jan. 23 at 12:16 PM
$ELTP Maybe this quiet period is the "calm before the storm" and the next PR is a buyout offer of FDA approval of something in the pipeline?? Most Likely Buyers of ELTP (Strategic Fit + Acquisition Behavior). Hikma and Teva have the infrastructure, the appetite, and the portfolio alignment to make Elite an immediately accretive acquisition. ⭐ 1. Hikma Pharmaceuticals Why they fit: One of the largest U.S. opioid‑generic manufacturers Deep experience with Schedule II controlled substances Actively acquires small U.S. generic companies Would immediately benefit from Elite’s abuse‑deterrent technology Why they’d want ELTP: Hikma has been expanding its controlled‑substance portfolio and could bolt Elite’s products directly into its distribution network. OR Teva Pharmaceuticals Why they fit: Largest generic drug company in the world Frequently acquires ANDAs and small specialty‑pharma companies Already operates in the opioid‑generic space
0 · Reply
FightingIrish33
FightingIrish33 Jan. 22 at 9:00 PM
$ELTP Because ELTP is a micro‑cap specialty pharma with revenue, approved products, and a pipeline, the most likely offer would be based on: A premium to the current share price Value of existing revenue streams Value of pipeline assets (especially abuse‑deterrent opioids) Strategic value to the acquiring company For companies like ELTP (sub‑$200M market cap), the standard takeover premium is: 50%–100% for companies with modest revenue 100%–200% for companies with strategic assets Bottom Line A realistic acquisition offer for ELTP would most likely fall in the range of: 2×–4× the current share price
0 · Reply
FightingIrish33
FightingIrish33 Jan. 22 at 8:55 PM
$ELTP 2 months...not a word......
0 · Reply